Subscription price freeze!
Subscriptions to the new volumes of our journals are now available via our shop at 2009 prices.
Submit a manuscript
Antiviral Therapy is one of the leading journals in virology. Why not submit a manuscript today via our online submission system?Editors-in-Chief: Douglas D Richman & Joep MA Lange
2009 ISI impact factor: 4.32
Antiviral Therapy (an official publication of the International Society of Antiviral Research) is an international, peer-reviewed journal devoted to publishing articles on the clinical development and use of antiviral agents and vaccines, and the treatment of all viral diseases. Antiviral Therapy is one of the leading journals in virology and infectious diseases.
The journal is comprehensive, and publishes articles concerning all clinical aspects of antiviral therapy. It features editorials, original research papers, specially commissioned review articles, letters and book reviews. The journal is aimed at physicians and specialists interested in clinical and basic research.
Features
♦ Early online publication
♦ New HTML versions of articles
♦ A leading Editorial Board ensuring high-quality standards
♦ Worldwide readership
♦ Articles are included in major indexing and abstracting services
Recently published
Spotlight on drug-resistant and vaccine-escape HBV mutants (Volume 15 Issue 3 Part B)
A mounting challenge in the management of hepatitis B virus is the emergence of drug-resistant mutants. To address the latest issues and advancements in the field, the US Centers for Disease Control and Prevention (CDC) convened a symposium in June 2009 entitled Drug-resistant and Vaccine-escape Hepatitis B Virus Mutants: Emergence and Surveillance. The CDC and international experts presented topical updates – such as the transmission of mutants, course of infection and patient care – which are reviewed in a specially commissioned Spotlight Issue of Antiviral Therapy. Editors Chong-Gee Teo and Stephen A Locarnini anticipate this compilation will spawn further deliberation into how mutants might interfere with treatment efficacy, alter the natural history of hepatitis B, undermine vaccination programmes and become further transmitted.
Also recently published in Antiviral Therapy: Late presentation of HIV treatment in Europe (Volume 15 Supplement 1) and the abstracts from International HIV & Hepatitis Virus Drug Resistance Workshop & Curative Strategies (Volume 15 Supplement 2).
Please contact the Editorial Office for more information about publishing a supplement.
ISSN: 1359-6535 (print); 2040-2058 (online)